ストックスクリーナーアプリを入手
4.38
6.61%
-0.31
アフターアワーズ：
4.40
0.02
+0.46%
前日終値:
$4.69
開ける：
$4.69
24時間の取引高:
790.32K
Relative Volume:
0.82
時価総額：
$198.03M
収益：
当期純損益:
$-85.57M
株価収益率:
-2.2853
EPS:
-1.9166
ネットキャッシュフロー:
$-72.14M
1週間 パフォーマンス:
-7.79%
1か月 パフォーマンス:
-44.20%
6か月 パフォーマンス:
-89.51%
1年 パフォーマンス:
-85.06%
1日の値動き範囲:
$4.365
$4.795
1週間の範囲:
$4.365
$5.12
52週間の値動き範囲:
$4.01
$54.97
Sionna Therapeutics Inc Stock (SION) Company Profile
名前
Sionna Therapeutics Inc
セクター
電話
617-819-2020
住所
21 HICKORY DRIVE, SUITE 500, WALTHAM
Compare SION vs VRTX, MRNA, REGN, ARGX, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SION
Sionna Therapeutics Inc
|
4.38 | 198.03M | 0 | -85.57M | -72.14M | -1.9166 |
VRTX
Vertex Pharmaceuticals Inc
|
485.22 | 122.98B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
216.25 | 86.33B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
753.12 | 77.54B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
802.64 | 50.47B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
188.44 | 40.39B | 742.00K | -1.37B | -1.07B | -7.0731 |
Sionna Therapeutics Inc Stock (SION) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-08-10 | ダウングレード | BTIG Research | Buy → Neutral |
| 2026-08-10 | ダウングレード | Citizens | Mkt Outperform → Mkt Perform |
| 2026-08-10 | ダウングレード | Guggenheim | Buy → Neutral |
| 2026-08-10 | アップグレード | RBC Capital Mkts | Underperform → Sector Perform |
| 2026-08-10 | ダウングレード | Raymond James | Strong Buy → Mkt Perform |
| 2026-08-10 | ダウングレード | Stifel | Buy → Hold |
| 2026-08-10 | ダウングレード | Wedbush | Outperform → Neutral |
| 2026-05-05 | 開始されました | Wedbush | Outperform |
| 2026-02-24 | 開始されました | Citizens | Mkt Outperform |
| 2025-12-01 | ダウングレード | RBC Capital Mkts | Sector Perform → Underperform |
| 2025-11-19 | 開始されました | BTIG Research | Buy |
| 2025-09-03 | 開始されました | RBC Capital Mkts | Sector Perform |
| 2025-09-03 | 開始されました | Raymond James | Strong Buy |
| 2025-03-04 | 開始されました | Guggenheim | Buy |
| 2025-03-04 | 開始されました | Stifel | Buy |
| 2025-03-04 | 開始されました | TD Cowen | Buy |
すべてを表示
Sionna Therapeutics Inc (SION) 最新ニュース
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sionna Therapeutics, Inc.SION - GlobeNewswire Inc.
Ra Capital Management sells $21.8m in Sionna Therapeutics shares By Investing.com - Investing.com Nigeria
Ra Capital Management sells $21.8m in Sionna Therapeutics shares By Investing.com - Investing.com Canada
RA Capital’s Sionna (NASDAQ: SION) stock sale wasn’t under a preset trading plan - Stock Titan
Sionna Therapeutics (Nasdaq:SION)Stock Analysis - Simply Wall Street
Ra Capital Management sells $21.8m in Sionna Therapeutics shares - Investing.com
Sionna Therapeutics CMO Charlotte McKee Granted RSUs and Stock Option Repricing Announced - Kalkine Media
Sionna (SION) cuts CFO option price to $7.18 - Stock Titan
Sionna Therapeutics (SION) cuts CLO's option price and adds new RSUs - Stock Titan
Sionna Therapeutics (SION) cuts CEO option exercise price - Stock Titan
Sionna Therapeutics, Inc. (SION) Stock Analysis: Unpacking a 192% Potential Upside in the Biotech Space - DirectorsTalk Interviews
Sionna (SION) cuts nearly half its jobs to back one cystic fibrosis program - Stock Titan
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sionna Therapeutics, Inc.SION - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sionna Therapeutics, Inc.SION - FinancialContent
Sionna Therapeutics faces securities fraud prob... - Pluang
SIONNA THERAPEUTICS INVESTIGATION ALERT: Bragar Eagel & - GlobeNewswire
Bronstein, Gewirtz & Grossman, LLC Encourages Sionna Therapeutics - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Sionna Therapeutics, Inc. (SION) And Encourages Shareholders to Reach Out - ACCESS Newswire
SION INVESTIGATION: Investigation Launched into Sionna - GlobeNewswire
Sionna Therapeutics stock plunges 91% after fai... - Pluang
Securities Fraud Investigation Into Sionna Therapeutics, - GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sionna Therapeutics, Inc.SION - financialcontent.com
Robbins LLP Reminds Investors it is Investigating Sionna Therapeutics for Potential Securities Violations - GlobeNewswire
Securities Fraud Investigation Into Sionna Therapeutics, - GlobeNewswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Sionna Therapeutics, Inc. (SION) And Encourages Stockholders to Connect - ACCESS Newswire
Sionna Therapeutics, Inc. (SION) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Sionna (SION) Earnings Reading: Profit Per Share Clears Its Benchmark in the Latest Reading; Price Move - vinanet.vn
Vertex Pharmaceuticals' Rally Has a New Engine -- and Wall Street Thinks the Best Is Still Ahead - Yahoo Finance
Vertex Pharmaceuticals' Rally Has a New Engine -- and Wall Street Thinks the Best Is Still Ahead - The Motley Fool
2026-08-20 | Sionna Therapeutics, Inc. (SION) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation | NDAQ:SION | Press Release - Stockhouse
Sionna (SION) Quarterly Figures: The Bottom-Line Figure Beats Its Comparison in the Current Update; Trading Response: The Share Price Adds 5.22% for the Current SessionTangible Book Value - vinanet.vn
Robbins LLP Reminds Stockholders it is Investigating the Recent Stock Drop of Sionna Therapeutics - PR Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Sionna Therapeutics, Inc. (SION) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Sionna shares plunge 92% after Phase 2a trial o... - Pluang
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
Sionna Therapeutics (SION) Securities Investigation NoticeLevi & Korsinsky - PR Newswire
Investigation Launched into Sionna Therapeutics, Inc. (SION), Robbins Geller Rudman & Dowd LLP Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm - Business Wire
Securities Fraud Investigation Into Sionna Therapeutics, Inc. (SION) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm - WBOC TV
Securities Fraud Investigation Into Sionna Therapeutics, Inc. (SION) Announced – Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz - FinancialContent
Robbins LLP is Investigating the Recent Stock Drop of Sionna Therapeutics; Contact the Firm for Information - Business Wire
Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving Sionna Therapeutics (SION) - GlobeNewswire
SION Investors Have Opportunity to Join Sionna Therapeutics, Inc. Fraud Investigation with SBS Law - The AI Journal
SION Investors Have Opportunity to Join Sionna Therapeutics, Inc. Fraud Investigation with SBS Law - lincolnjournal.com
SION INVESTOR ALERT: Investigation Launched into Sionna Therapeutics, Inc., Robbins Geller Rudman & Dowd LLP Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm - The Daily Tribune News
SION Investors Have Opportunity to Join Sionna Therapeutics, Inc. Fraud Investigation with SBS Law - Business Wire
symbol__ Stock Quote Price and Forecast - CNN
Sionna Therapeutics (NASDAQ:SION) Lowered to Strong Sell Rating by Wall Street Zen - MarketBeat
SION Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Sionna Therapeutics (SION) - Business Wire
SION SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Sionna Therapeutics - PR Newswire
Sionna Therapeutics (SION) Resets After Trial Miss, Is The Discount Now Too Deep? - Yahoo Finance
Sionna Therapeutics Inc (SION) 財務データ
収益
当期純利益
現金流量
EPS
Sionna Therapeutics Inc (SION) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| RA Capital Healthcare Fund, L. | Director |
Sep 17 '26 |
Proposed Sale |
6.33 |
3,448,811 |
21,834,318 |
0 |
| ORBIMED ADVISORS LLC | Director |
Jul 07 '26 |
Sale |
44.86 |
85,918 |
3,854,281 |
2,469,959 |
| Thompson Peter A. | Director |
Jul 07 '26 |
Sale |
44.86 |
85,918 |
3,854,281 |
2,469,959 |
| Fitzpatrick Jennifer | Chief Legal Officer |
Jul 06 '26 |
Sale |
43.60 |
10,250 |
446,862 |
0 |
| Fitzpatrick Jennifer | Chief Legal Officer |
Jul 06 '26 |
Option Exercise |
6.11 |
10,250 |
62,628 |
10,250 |
| JENNIFER FITZPATRICK | Officer |
Jul 06 '26 |
Proposed Sale |
43.99 |
10,250 |
450,898 |
0 |
| ORBIMED ADVISORS LLC | Director |
Jun 30 '26 |
Sale |
45.50 |
115,844 |
5,270,902 |
2,555,877 |
| Thompson Peter A. | Director |
Jun 30 '26 |
Sale |
45.50 |
115,844 |
5,270,902 |
2,555,877 |
| OrbiMed Private Investments VI | Shareholder |
May 29 '26 |
Proposed Sale |
42.80 |
1,082,480 |
46,330,144 |
0 |
| Thompson Peter A. | Director |
May 27 '26 |
Sale |
44.49 |
101 |
4,493 |
2,671,721 |
4.80%
大文字化:
|
ボリューム (24 時間):